Abstract
We used a model of combined bone marrow and heart transplantation in which tolerance and stable chimerism is induced after conditioning with fractionated irradiation of the lymphoid tissues and anti-T 
Introduction
The role of CD4 + CD25 + Treg cells and natural killer (NK) T cells in the induction of immune tolerance and acceptance of organ and/or bone marrow transplants has been studied extensively [1] [2] [3] [4] [5] [6] [7] [8] . In the case of Treg cells, both naturally occurring (nTregs) and induced (iTregs) cells can promote tolerance 5, 6 Whereas the naturally occurring Treg cells suppress immune responses to a broad spectrum of alloantigens in vitro and in vivo, the induced Treg cells have been shown to suppress responses to specific alloantigens that are the targets of tolerance 5, 6 . The effector mechanisms of immune suppression involve both cell contact interactions with conventional T cells (Tcon cells) that initiate responses to alloantigens, and the secretion of cytokines such as IL-10 that reduce inflammatory responses and Tcon cell immunity 9, 10 . The suppression of Tcon cell immunity by Treg cells has been shown to involve the interactions between the programmed death-1 (PD-1) T cell activation molecule, and the ligand, PDL-1 11 . Blocking of this interaction abrogates tolerance to cardiac allografts induced by CTLA-4-Ig treatment 12 . Upregulation of PD-1 on Treg cells has been associated with increased IL-10 production 13, 14 .
NKT cells differ from conventional T cell subsets because the NKT cell TCR recognizes glycolipids associated with the non-polymorphic antigen presenting molecule, CD1d, whereas the TCR of the conventional T cell subsets recognizes peptides associated with the highly polymorphic antigen presenting molecules, MHC Class I and II 15, 16 . There are 2 major subtypes of NKT cells, type I and type II, that express either an invariant TCRα chain that contains a segment encoded by the Jα18 gene, or a non-invariant TCRα chain respectively 17, 18 . Jα18 -/-mice are deficient in the type I with the invariant TCR; whereas CD1d -/-mice are deficient in both types as well as the CD1d TCR ligand 17 . NKT cells have regulatory functions that promote transplantation tolerance and suppress GVHD after bone marrow
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Treg cells and change Treg cell function [21] [22] [23] .
Previous studies of bone marrow transplantation that used hosts conditioned with fractionated irradiation of the lymphoid tissues (total lymphoid irradiation; TLI) and anti-T cell antibodies showed that prevention of GVHD by the conditioning regimen required the presence of both host NKT cells and donor Treg cells 23 . The NKT cells interacted with the Treg cells, and NKT cell production of IL-4
enhanced Treg cell expansion and secretion of IL-10 that prevented GVHD 23 . Similarly, the same conditioning regimen promoted tolerance to combined organ and bone marrow transplants, and hosts became stable mixed chimeras with long-term acceptance of donor but not third party heart grafts 8, 24 .
Tolerance required the presence of both host NKT cells and host Treg cells, since pretransplant depletion of Treg cells in wild type hosts or the deficiency of NKT cells in CD1d -/-hosts prevented engraftment of the organ and bone marrow transplants 24 . However, interactions between the T cell subsets were not studied 24 .
The goal of the current study was to determine whether the host NKT cells, Treg cells and Tcon cells can interact, and the mechanisms of interactions that can facilitate tolerance in the above model of combined organ and bone marrow transplantation. We found that tolerance was dependent on Treg production of IL-10 that was in turn dependent on NKT cell production of IL-4. 
Cardiac transplantation and monitoring for graft survival
Neonatal C57BL/6 heart grafts were transplanted into a pouch in the ear pinna of BALB/c hosts on day 0 according to the procedure described by Trager et al. 30 . Heart grafts were monitored daily for visible contractions, and survival was based on the time interval after transplantation when contractions stopped.
Bone marrow transplantation and TLI
The bone marrow harvesting and transplantation procedure was performed as previously described 8 .
TLI was delivered to the lymph nodes above and below the diaphragm, thymus and spleen with lead shielding of the skull, limbs, pelvis, and tail using a 250Kv X-ray machine 31 . Ten doses of 240cGy each were administered starting on the day of heart transplantation using 5 doses per week 24 . The last dose of TLI was administered to BALB/c mice 24h before the allogeneic bone marrow cell infusions on day 15
after heart transplantation. . Phycoerythrin conjugated CD1d-tetramers were obtained from the National Institutes of Health (NIH)
Immunoflourescent staining reagents and monoclonal antibodies
Tetramer Facility, Rockville, MD.
Immunoflourescent staining and chimerism analysis
Single cell suspensions of blood or spleen cells were stained for surface markers with appropriate mAbs at 4°C in staining buffer containing propidium iodide and Fc receptor blocking antibodies as described 
Statistical Analysis
Statistical analyses of differences in heart graft survival between different groups of mice were performed using the log-rank test of Kaplan-Meier plots at day 100. Comparisons of the fraction of mice in different groups that were chimeras were performed by chi-square analysis. Comparison of mean percentages of absolute numbers of T cells, and subsets in the spleen and cytokine analysis of different groups of mice were made using two-tailed Student's t-test of independent means.
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Results

Tolerance is dependent on Tregs, their expression of IL-10, and NKT cells
The experimental scheme shown in Figure 1A has been used previously 24 Figure 1A) . Figure 1B shows the survival of C57BL/6 heart grafts in the BALB/c recipients during a 100-day observation period. All wild type recipients that were conditioned and given combined bone marrow and heart transplants without Treg depletion maintained their grafts for at least 90 days. Previous studies showed that the C57BL/6 bone marrow cells must be injected to achieve acceptance of the C57BL/6 heart grafts 8 . Figure Since full in vivo suppression of alloimmunity or autoimmunity by Tregs has been shown to be dependent on their secretion of IL-10 10,33 , the add back experiments were repeated using purified Tregs from IL-10 -/-instead of wild type BALB/c mice. As shown in Figure 1C , the injection of the IL-10
Tregs failed to restore long-term acceptance of the heart grafts, and all were rejected by about day 80 (p= 0.05; IL-10 -/-vs wild type). Although addback of wild type Treg cells to wild type hosts depleted of Tregs restored graft acceptance, the add back failed to restore acceptance in the invariant NKT cell deficient Jα18 -/-hosts ( Figure 1C ).
Chimerism is dependent on Tregs, their expression of IL-10, and on NKT cells
Recipients in the groups shown in Figures 1B and C were not only monitored for heart graft survival, but also for the development of chimerism at days 28 and 100 after bone marrow transplantation. Figure   1D shows Figure 1D ). Injection of IL-10 -/-Tregs failed to restore chimerism in T cells, or above 10% among macrophages, granulocytes, and B cells in the majority of recipients ( Figure 1D ). Substitution of Jα18 -/-hosts for wild type hosts resulted in failure to restore chimerism with the addback of wild type Tregs ( Figure 1D ). In addition, Jα18 -/-hosts without depletion failed to develop chimerism ( Figure 1D ). Thus, the patterns of heart graft acceptance and those of bone marrow graft acceptance were similar. When the percentage of donor type cells in the different lineages was examined at day 100 for wild type mice without depletion, then the patterns were similar to that of day 28 (Supplementary Figure 1B) . This indicated that the mixed chimerism established in the recipients was stable.
Upregulation of IL-10 and PD-1 by Treg cells after heart and bone marrow transplantation is enhanced by NKT cells in an IL-4 dependent manner
In further experiments, the cytokine secretion patterns of Tregs from the wild type transplant recipients were compared to Tregs from a second type of NKT cell deficient (CD1d -/-) recipient to determine whether the deficiency in host NKT cells affected the secretion patterns induced by in vitro activation. , we stained CD8 + T cells for both markers as shown in Figure 3D . Figure 3D ). Tim-3 expression was near background among CD4 + Tcon cells in all groups of mice (data not shown).
In order to study the importance of NKT cell deficiency on cytokine secretion pattern of host type CD4 + Tcon cells in the transplant mice, the protocol outlined in Figure 2B 
CD1d
-/-recipients. The purified cells were stimulated in vitro and cytokine concentrations in the supernatants were measured. There was a significant increase in IL-10, IL-4, and IFNγ secretion when untreated wild type mice were compared to transplanted wild type mice ( Figure 3E ) In order to determine whether NKT cell secretion of IL-4 also had impact on C57BL/6 bone marrow graft acceptance, the hosts observed in Figures 4A and B were assayed for chimerism in the spleen.
Chimerism was assayed by staining for donor type (H-2K b+ ) cells in the splenic mononuclear cell gate.
As shown in Figure 4C , the mean percentage of donor type cells in the Jα18 -/-transplanted mice were
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However, the addback of IL-4 -/-NKT cells resulted in no significant change. In summary, not only is the Tim-3 and/ or PD-1 receptor upregulation dependent on NKT cell secretion of IL-4, but also the acceptance of bone marrow transplants and development of robust chimerism.
Upregulation of PD-1 and Tim-3 is induced by TLI and ATS conditioning and declines after transplantation of bone marrow
In further experiments, TLI and/ or ATS conditioning alone was compared to conditioning combined with heart and bone marrow transplantation on the upregulation of PD-1 on T cells. For personal use only. at STANFORD UNIV MED CTR on January 3, 2012.
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The addition of transplantation to TLI+ATS did not make a significant difference. In summary, the TLI+ATS conditioning regimen markedly increased PD-1 upregulation on all 3 T cell subsets, and no significant increment was induced by transplant procedures. Figure 5D shows the kinetics of PD-1 upregulation on host type CD4 + CD25 -and CD4 + CD25 + T cells in the blood after TLI+ATS conditioning combined with transplantation. Mean percentages of PD-1 hi cells
showed a peak of 65% to 80% at completion of conditioning, and a rapid decline by day 30, and a slower decline to baseline by day 85. Similar kinetics of PD-1 and Tim-3 upregulation was observed on CD8 + T cells in the blood ( Figure 5E ). However, the peak mean percentages of PD-1 + cells or PD-1 + Tim-3 + cells were delayed until day 20, and peak percentages were less (25 to 35%) than the CD4 + T cells. A rapid decline to day 50 was followed by a slow decline to baseline at day 85.
Discussion
Previous studies showed that conditioning of hosts with TLI and ATS induced tolerance to combined organ and marrow transplants, and host NKT and Treg cells were required 8, 24 . In the current study, we demonstrate that tolerance, and chimerism are restored by transferring Treg cells from wild type BALB/c mice to the Treg depleted wild type BALB/c recipients of heart and bone marrow transplants.
The Treg restoration of tolerance and chimerism was dependent on their ability to produce IL-10, since Additional experiments showed that the increased expression of PD-1 on Tregs, CD4 + Tcon and CD8 + T cells was observed after conditioning of wild type BALB/c mice with TLI and ATS without transplantation of heart or bone marrow grafts. This is consistent with previous reports that TLI induces a Th2 bias in NKT cells 35 . Thus, the altered host immune milieu promotes the acceptance of the bone marrow transplants, that in turn results in the development of stable mixed chimerism. The mechanisms by which mixed chimerism promote tolerance have been studied exhaustively, and include clonal deletion 36, 37 . As in other models, PD-1 expression has been shown to suppress conventional T cell alloreactivity, and provide a co-stimulatory signal that enhances IL-10 secretion of regulatory T cells 11, 12, [38] [39] [40] .
Although our model of tolerance induction requires the injection of donor bone marrow cells that leads to chimerism and clonal deletion 8 , mixed chimerism itself is not sufficient to induce tolerance to the heart grafts. When TLI was used for posttransplant conditioning instead of TLI and ATS, then mixed chimerism was achieved uniformly, but 7 of 8 heart grafts were rejected before day 60 8 . Therefore, it is likely that immune regulation in addition to clonal deletion associated with chimerism are required to induce tolerance to organ grafts in this model. The findings in the current study can be extrapolated to other mouse strains and to other species. Tolerance after 10 doses of TLI and 5 doses of ATS was also induced when mouse donors were BALB/c and recipients were C57BL/6 8 (the reverse of the current study), or when vascularized heart graft and bone marrow donors were ACI rats, and TLI and ATS conditioned recipients were Lewis rats 41 . More importantly, the findings could be extrapolated to humans, and tolerance could be induced in about 70% of recipients given combined kidney and hematopoietic cell transplants from HLA matched donors after conditioning with 10 doses of TLI and 5 doses of ATG 42, 43 . The rationale for using completely posttransplant conditioning was the ability to extend the protocol in humans to transplants from deceased donors, since conditioning cannot be scheduled in advance. In conclusion, interactions between NKT and Treg cells are required to promote tolerance in this system, and the regimen has been translated to the successful induction of tolerance in humans.
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